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Abstract 
In the last decades significant progress has been carried out leading to 
significant advances in the development of engineered tissues, thanks to 
taking into account three fundamental components: the cells to address 
tissue formation, a scaffold useful as substrate for tissue growth and 
development, growth factors and/or biomechanical stimuli to address the 
differentiation of cells within the scaffolds. In particular, mechanical 
stimuli are known to play a key role in bone tissue formation and 
mineralization. 
Mechanical actuators, namely bioreactor systems, can be used to enhance 
in vitro culture steps in the overall cell-based tissue engineering strategy of 
expanding in vitro a stem cell source to be cultured and differentiated on a 
three-dimensional scaffold, aiming at implanting this scaffold in vivo. 
The purpose of this study is thus to design a stand-alone perfusion/
compression bioreactor system. The developed prototypal system allows to 
apply physical stimuli mimicking native loading regimens. The results 
obtained in human bone marrow stem cells (hBMSCs)  onboard of a 3D 
graphene/chitosan scaffold indicate that their exposure to a controlled 
dynamic environment is suitable to address bone tissue commitment. 
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Abstract 
Undanfarana áratugi hefur orðið mikil framför á sviði vefjaverkfræði og 
frumumeðferða. Það má helst nefna þrjá þætti sem hafa leitt til þessara 
framfara: mikilvægar uppgötvanir í frumuræktunum, þróun og hönnun á 
lífstoðefnum sem nota má í burðarvirki meðal annars til að örva 
vefjamyndun í gegnum mekaníska og lífræna örvun. Mekaníska örvunin er 
talin vera sérstaklega mikilvæg þegar kemur að því að hanna og smíða 
beinvef, sérstaklega þegar kemur að steinefnamyndun í frumunum og 
myndun á utanfrumuefni sem gegnir lykilhlutverki í lífeðlisfræðilegri 
virkni beinvefs. 
Tæki sem hægt er að nota til að örvar frumuvöxt og beinmyndun munu í 
framtíðinni gegna mikilvægu hlutverki í þróun beinvefjar sem ætlað er að 
gegna hlutverki í læknisfræðilegri meðferð. 
Markmið þessarar doktorsritgerðar var að þróa og smíða tæki (bioreactor) 
sem getur líkt eftir þeim áhrifum sem frumur verða fyrir í beinmyndun. Um 
er að ræða tæki sem þarf ekki að staðsetja inni í frumuræktunarskáp og 
getur örvað vefjmyndunina bæði með mekanískum hætti og flæði sem 
tryggir næringu innan 3D burðarvirkisins. Heildarniðurstaða verkefnisins 
var að mesenkímal stofnfrumur fjölga sér og sérhæfast betur þegar þær eru 
ræktaðar á grafín/ kítósan burðarvirki í tækinu heldur en þegar þær eru ekki 
ræktaðar í slíku tæki. Um er að ræða tæki sem gæti nýst við rannsóknir á 
beinmyndun í framtíðinni.  
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1. Introduction
Although survival expectancy of the European population has increased to 
a median age of 75 years for men and 82 years for women, inappropriate 
lifestyle factors lead to a sharp increase in obesity and poor physical 
activity triggering related bone disorders [1]. 
Bone repair and regeneration via tissue engineering strategies are thus 
considered a significant clinical options, given that a number of studies 
reported complications, shortcomings and limitations using autologous and 
allogenic functional bone grafts  [2-8].  
In fact, albeit autografts have the most important properties required for a 
bone graft material (histocompatible, non-immunogenic and endowed with 
fundamental elements to achieve osteoconduction (i.e. scaffolds), 
osteoinduction (i.e. specific growth, as BMPs) and osteogenesis (i.e. 
osteoprogenitor cells), they show a number of disadvantages. As an 
example, they require two operations, one to obtain the patient own bone 
tissue (normally extracted from the iliac crest) and one to implant the new 
tissue construct [9], which makes this kind of transplant expensive both 
from an economic point of view and for the donor site injury [10-12]. 
Furthermore, this treatment may be not useful in case of a large defect.  
Allografts might be used to solve these limits, in particular as bone tissue is 
often obtained from a cadaver. However, allografts show disadvantages 
such as immunogenic reactions, risk of infection, limited osteoinduction, in 
addition to the requirement of a treatment to devitalize the cell component 
(i.e. freeze drying or irradiation) [13-15]. 
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Other techniques, including the use of bone cement fillers, distraction 
osteogenesis or bone morphological proteins are also affording good results 
in terms of bone repair, although none possess all of the ideal 
characteristics: no size restrictions, biological safety, long shelf life, high 
osteoinductive and angiogenic potentials and reasonable costs.  
In this regard, bone tissue engineering represents a novel treatment aiming 
at enhancing bone repair and regeneration [16] joining the skills of 
different specialists (i.e. engineers, surgeons, biologists) in order to define 
standard protocols useful for a clinical use.  
In the past two decades significant progress was carried out in the field of 
biomaterials and cell therapy, leading to significant advances in the 
development of engineered tissues. To this aim, three fundamental 
components need to be included: appropriate cells to prime neotissue 
formation, a scaffold as a substrate for cell growth and development into a 
structured biological tissue, growth factors and/or biomechanical stimuli to 
address the cell phenotype within the scaffold [17,18]. 
The cells are the main responsible for tissue formation and to this aim, 
autologous primary cells are intended as the best choice. Bone marrow 
mesenchymal stem cells (BM-MSCs) [19-24], adipose stem cells (ADSCs) 
[25-27] and induced pluripotent stem cells (iPSCs) [28-32] in particular, are 
considered as suitable for the task. 
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Figure 1.1 - Scaffolds for tissue engineering approach. A, PLGA; B, PLA; 
C, Calcium Phosphate; D, Chitosan; E, Alginate. 
A B C
D E
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Most of the information about cell differentiation protocols was derived 
culturing these progenitors cells in monolayer static condition in the 
presence of differentiation media. However, to develop tissue constructs for 
potential in vivo implantation, porous scaffolds are needed as a support 
mimicking the 3D tissue properties [33]. Novel structures and fabrication 
techniques are continuously investigated in this respect. The use of 
synthetic polymers as poly lactic acid (PLA) [34-40] and poly lactic-co-
glycolic acid (PLGA) [41-44], ceramic materials as calcium phosphate 
(CaP) [45-57], natural polymers as alginate [58-63] and chitosan [64-67] 
hydrogels, was widely reported in the literature. Bulk material properties 
and fabrication techniques are determining specific characteristics in terms 
of relevant properties of a scaffold, such as porosity, stiffness (Young’s 
modulus) and biodegradability. 
In addition to their supportive role, scaffolds might be used as functional 
structures useful to deliver biological active molecules, such as growth 
factors [68-69]. This configuration is however still missing of the 
biomechanical stimuli (i.e. dynamic condition), recognized as fundamental 
cues actives over natural tissues.  
Indeed, human bone tissue is normally subjected to two forms of 
biomechanical stimuli: compression/tension loading generating fluid 
movement through lacunae (shear stress, 0.8 - 3 [Pa]) and physical 
deformation generating structural change (strain <2000 [µε]). 
In a way to reproduce these physiologic mechanical solicitations, actuators 
-  namely bioreactor systems - were used in vitro to prime cell-based 3D 
tissue constructs, aiming at the following implant in vivo [70].  
!19
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Figure 1.2 - Example of bioreactors for tissue engineering approaches. A, 
Rotating wall; B, magnetic stirring; C, perfusion; D, compression. [71] 
Several configuration were designed for different kind of stimuli. Most 
diffused bioreactor systems are: rotating wall systems, spinner flask 
systems, perfusion system, compression and strain systems [72].  
Different studies have demonstrated that a combination of “dynamic 
culture” enriched with proper mechanical stimulation may promote 
efficient progenitor cell expansion and differentiation in vitro [73-79].  
The recent scientific literature about this paradigm is reviewed in the 
following, overviewing the proposed bioreactor design, the specific 
physical stimulus applied and the performed osteogenic differentiation 
evaluation (Table 1.1). 
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Bioreactors used for bone tissue engineering were classified by applied 
physical stimuli.  
 Inasmuch as perfusion is concerned, Ding et al. 2016 developed a 
computer-controlled perfusion bioreactor aiming to automate: initial filling, 
cell seeding and prolonged cell/tissue culture. Chemo-optic micro-sensors 
were included to monitor non-invasively the levels of oxygen and pH 
during the culture period.  A standard incubator was used to maintain 
standard culture condition. Ovine bone marrow stromal cells were seeded 
onto porous mineral scaffold. A perfusion flow rate of 0.25 [mL/min] was 
maintained during the dynamic differentiation protocol. After 10 days of 
incubation, the mineral scaffolds was implanted in vivo for 4 weeks. Bone 
formation was observed in bioreactor cultured scaffolds compare to control, 
revealing the capability of activation larger viable bone graft material, even 
after shorter incubation time of graft material. 
Nguyen et al. 2016 explored the influence of applied flow in the tubular 
perfusion system (TPS) bioreactor on the osteogenic differentiation of 
human mesenchymal progenitor cells (hMPCs) onboard alginate scaffolds. 
During the dynamic culture the TPS bioreactor was placed into an 
incubator and a flow rate of 3 [mL/min] was applied. The results 
demonstrated enhanced expression of osteogenic markers in cells cultured 
under perfusion flow and the addition of exogenous growth factors. 
Sinlapabodin et al. 2016 used: a perfusion bioreactor realizing an uniform 
axial distribution; Thai silk fibroin (SF)/gelatin (G)/hydroxyapatite (HA) 
scaffolds as a tool to evaluate the suitable perfusion flow rate; rat bone 
marrow derived stromal cells (rMSC) were used in during osteogenic 
differentiation. The bioreactor was placed inside a CO2 incubator for cell 
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culture, thus, it can’t be considered a stand-alone system. For the dynamic 
culture different perfusion flow rates (1, 3 and 5 [mL/min]) were tested. 
The perfusion flow rate of 3 ml/min gave the highest rMSC osteogenic 
differentiation on a SF/G/HA scaffold than other flow rates, as observed 
from the significantly highest number of alkaline phosphate (ALP) enzyme 
activity and the calcium content without any significant cell growth. 
 Among devices applying only compression, Brunelli et al. 2017 
proposed the use of a BOSE Bioreactor in combination with 3D hybrid 
(polycaprolactone/Collagen) scaffolds and human embryonic mesodermal 
progenitor cells (hES-MPs). As stimulus a 5% strain ramp followed by 
peak-to-peak 1% strain sinewaves at 1 Hz for 15 min were applied. Cell 
viability, DNA content and osteocalcin expression were tested. Samples 
were further stained with 1% osmium tetroxide in order to investigate 
tissue growth and mineral deposition by micro-computed tomography 
(µCT). The results suggest how cyclic stimulation: is a trigger for delayed 
proliferative response of cells; play an important role in the mineralization 
processes. 
Maeda et al. 2017 designed a custom-made bioreactor system for cyclic 
compression loading. An ex vivo scaffold (thickness of 3 [mm])  was 
obtained from the tibias of 0-day-old chick. Cyclic compression (3-4 
[cycles/min]), with an amplitude of 0.3 N corresponding to 1 to 2% 
compressive strain was applied to immature bone specimen during a 3-day 
culture period. Stress-strain relationship was evaluated before and after the 
dynamic culture. ALP, cell viability and tissue calcification were also 
verified. The elastic moduli of bone slices were significantly elevated at the 
end of the 3-day culture in the presence of cyclic compression; no 
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significant changes in the moduli were observed in the absence of cyclic 
compression. The increases in the moduli were coincided with the in- 
crease in calcified area in the bone samples. It was confirmed that 
immature bone can respond to compressive loading in vitro and 
demonstrate the growth of bone matrix, similar to natural, in vivo 
maturation. The elevation of the elastic moduli was attributable to the 
increased calcified area and the realignment of collagen fibers parallel to 
the loading direction.  
Revichandran et al. 2016 present a compression bioreactor system that 
applies cyclic compression Polycaprolactone-β/Tricalcium Phosphate 
(PCL/TCP) scaffolds seeded with Mesenchymal Stem Cells (MSC). A 
compression stimulus at physiological strain value of 0.22 [%] and a 
frequency of 1 [Hz] was applied for 4 weeks for 4 h per day. Osteonectin, 
COL1A1 (7 days) and ALP activity (14 days) were evaluated revealing an 
increased expression in dynamic condition compare to static group. 
 When both perfusion and compression were applied, Teng et al. 2016 
investigated the effects of cyclic compression, perfusion, dexamethasone 
(DEX) and bone morphogenetic protein-7 (BMP-7) on the proliferation and 
differentiation of human bone marrow stromal cells (hBMSCs) in 
polyurethane scaffolds. Dynamic culture was performed mixing six 
different conditions: 10% Cyclic compression at 0.5 and 5 Hz; 10 ml/min 
perfusion; 100 nM DEX; 100 ng/ml BMP-7; and 1 ml/min perfusion 
without mechanical and biochemical stimulation (control). On days 7 and 
14 cell proliferation, Runx2, COL1A1 and osteocalcin, osteocalcin content, 
calcium deposition, and the equilibrium modulus of the tissue specimen 
were evaluated. The obtained results suggest that BMP-7 and perfusion 
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enhance cell proliferation, whereas high frequency cyclic compression 
inhibits the proliferation and osteogenic differentiation of hBMSCs. Low 
frequency cyclic compression is more effective than DEX, but less 
effective compared with BMP-7 on the osteogenic differentiation of 
hBMSCs seeded on polyurethane scaffolds. Baumgartner et al. 2015 
observed the effect of a bioreactor realizing perfusion and uniaxial cyclic 
compression on electrospun nanocomposite scaffolds of poly-lactic-co-
glycolic acid and amorphous calcium phosphate nanoparticles (PLGA/a-
CaP) seeded with human adipose derived stem cells (ASCs). A perfusion 
flow rate of 0.3, 0.5, 2 [mL/min] was applied in combination with a cyclic 
compression of 5 [%] of strain and at 1 [Hz]  of frequency. Osteogenesis 
was analyzed on the protein level (osteopontin). The obtained results 
revealing how perfusion and compression allow the generation of linear 
cell density gradients and begin osteogenic differentiation of the stem cells. 
Li et al. 2014 designed a prototype of a bioreactor system including 
perfusion, cyclic compression, automatic substance exchange and feedback 
control of pH and PO2. The effect of dynamic culture was evaluated on 
mouse bone-marrow mesenchymal stem cells seeded in decalcified bone 
matrix (DBM). A perfusion flow rate of 10 [mL/min] was applied in 
combination with a cyclic compression of 5 [%] of strain and at 1 [Hz]  of 
frequency. The results shown higher cell densities, proliferation, 
phosphatase activity and calcium content in scaffolds maintained in 
dynamic culture compared to those in static culture. Furthermore, because 
its innovative features the bioreactor can be considered as a stand-alone 
system with a strong potential for long-term tissue culture. 
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Petersen et al. 2012 developed a perfusion/compression bioreactor system 
working with a perfusion flow rate of 5 mL/min and cyclic mechanical 
loading of 10 [%] of strain at 1 [Hz] of frequency. A macroporous scaffold 
made of  porcine collagen-I was seeded with primary dermal human 
fibroblasts. While mechanical loading resulted in a clear upregulation of 
procollagen-I and fibronectin production, scaffold stiffness showed to 
primarily influence matrix metalloproteinase-1 (MMP-1) secretion and 
cell-induced scaffold contraction. The results suggest that scaffold stiffness 
has only a temporary effect on cell behavior, while the impact of 
mechanical loading is preserved over time. 
The proposed review highlights recent promising results about engineered 
bone tissue construct obtained within mechanical actuation devices. 
Different kind of cells and 3D supports were used. The examined works 
suggest that perfusion and compression are biomechanical stimuli relevant 
for a proper tissue proliferation/differentiation. Particularly, it is noteworthy 
to observe that a perfusion flow rate plays an important role for cell 
proliferation in a range of 1-3 mL/min. Cell proliferation is inhibited when 
low frequency compression is applied, i.e.: high compression frequencies 
are preferred. Only two of the proposed devices might be defined stand-
alone; no bioreactor allows real-time analysis. 
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2. AIM 
Bioreactor systems were widely used, in tissue engineering to improve the 
proliferative and differentiate efficiency of in vitro cell cultures. 
Recent scientific literature suggest that perfusion and compression stimuli 
are fundamental cues to address a proper osteogenic differentiation.  
The purpose of this study is to show a stand-alone perfusion/compression 
bioreactor, originally developed as a synthesis of previous promising 
results obtained with mechanical actuation devices reported in the 
literature.  
Namely, perfusion will be applied to increase diffusive exchange and waste 
removal during a cell culture, thus, to increase cell survival within the core 
area of 3D engineered scaffolds.  
Compression stimulus will play a fundamental role for a proper osteogenic 
differentiation mimicking the physiological load bearing bone function. 
The device will be released as a stand-alone apparatus for incubator 
independent cell culture with the added value of a potential real-time/in-
line analysis of the tissue engineered bone construct. 
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3. Material and Methods 
The presented work was carried out within an agreement for the co-
direction of a PhD research/study between the University of Bologna 
(Italy) and the Reykjavik University (Iceland). 
The bioreactor system was designed, built and developed at the “Institute 
for Biomedical and Neural Engineering/Biomedical Technology 
Centre” (Reykjavik University, Reykjavik, Iceland) under the supervision 
of Professor Paolo Gargiulo providing facilities and training; the wet-lab 
procedures were carried out at the Bloodbanki (Landspitali Hospital, 
Reykjavik, Iceland) under the supervision of Professor Ólafur E. 
Sigurjónsson, providing facilities, training, reagents, cells; the analytical 
analysis were performed at the Mol & Cell Eng Lab (ICM) (University of 
Bologna, Cesena, Italy) under the supervision of Professor Emanuele D. 
Giordano providing facilities and training. 
Partial subvention to grant a bursary to the PhD candidate was provided by 
all the three mentioned Institutions. 
3.1 The bioreactor system 
A stand-alone perfusion/compression bioreactor system was designed and 
built up with the aim of improving proliferation, growth and differentiation 
of stem cells seeded onboard of scaffolds of interest. 
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Sensors were incorporated to monitor parameters such as pH and 
temperature in the cell culture environment. A Control Unit (CU) with a 
Graphical Unit Interface (GUI) was implemented in order to control the 
device and to acquire data from sensors in such a way to monitor these 
variables during the cell culture and to correct any of these if needed.  
3.1.1 A stand-alone apparatus 
A system of automatic replacement of the media was incorporated in order 
to facilitate the replacements of the media and also prevent contamination.  
For this purpose, two little peristaltic pump (Figure 3.1 - Welco WPX1) 
were used, one to feed fresh media into the bioreactor circuit, the other one 
to remove the waste media from the bioreactor circuit. This operation is 
completely automatized thanks to the CU present in the device, thus no 
manual operation is required by the operator. 
Furthermore, 3 heating pads (Figure 3.2) were placed in the bioreactor to 
maintain the temperature of the perfusion circuit at 37°C. 
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!  
Figure 3.1 - Welco WPX1 peristaltic pump used for the automatic media 
replacement system. 
!  
Figure 3.2 - Heating pad used to maintain the temperature of the perfusion 
circuit at 37°C. 
The temperature was constantly monitored and eventually corrected 
through the use of a temperature sensor (Figure 3.3, [A] - Sparkfun 
Electronics, DS18B20) within the media. 
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!  
Figure 3.3 - Sensors used to monitor cell culture parameters. A, 
Temperature sensor; B, pH sensor. 
Finally, a tank containing (5% CO2, 20% O2, 75% N) was used to 
guarantee the correct gas exchange; pH level of the media was constantly 
monitored by a pH probe (Figure 2.3, [B] - Phidgets, BNC pH Lab 
Electrode). 
3.1.3 A mechanical loading actuator 
To promote nutrient exchange and waste removal a perfusion 
apparatus ,based on a peristaltic pump (Figure 3.4, [A] - Welco WP10), was 
implemented allowing to tune flow rate in a range of 0.16 ÷ 5 mL/min for 
each one of the six chambers.  
A B
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!  
Figure 3.4 - Actuators. A, peristaltic pump used to apply perfusion; B, 
stepper motor with lead screw. 
To apply a proper mechanical stimulus, onto the tissue construct, a 
mechanical loading actuator was designed; this actuator, based on a stepper 
motor (Figure 3.4, [B] - NEMA 17-size hybrid bipolar stepping motor), 
allows to obtain a controlled compression tunable in a strain range of 1 ÷ 5 
% at different level of frequency 0.5 ÷ 5 Hz. 
3.1.2 A real-time/in-line monitor 
Taking into account the desired scaffold geometry and dimension, a custom 
chamber, based on the single well dimension, i.e. a 300 µL volume, of a 
standard 96 multiwell plate, was designed to allow to apply perfusion and 
compression over the 3D scaffold. Biocompatible material was used to 3D 
A B
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print (Materialise, Belgium) six chambers used to realize the core of the 
perfusion circuit of the bioreactor.  
In a way to perform a real time/in line analysis (i.e.: the analysis of the very 
same tissue construct at different time points) mobile units were conceived. 
For this reason, the chambers were connected to the perfusion circuit by 
Spyros/MicroClave devices (ICUMed, USA), realizing a simple detachable 
system (i.e.: the mobile unit) useful to prevent leakage and infection risk 
when real-time/in-line analysis (e.g.: spectrofluorometric analysis, 
fluorescence analysis; X-ray µCT for 3D imaging analysis) have to be 
performed. In order to evaluate the monitor, a specific culture was set-up. 
One CHT/G scaffold, hosting onboard human mesenchymal stem cells 
(hMSCs), was placed within a mobile unit cultured for 10 days in static 
traditional condition (i.e.: within a cell culture incubator). At day 10th, the 
mobile unit was moved into the bioreactor where perfusion and 
compression were transferred with the same regimens used in the previous 
experiment. After 24h (i.e.: day 11th), the mobile unit was transferred from 
the bioreactor system, processed by X-ray µCT (phoenix|x-ray Systems, 
nanotom s, GE) and then reconnected to the bioreactor. At the end of the 
test (i.e.: day 14th) the unit, thus the same scaffold, were processed for the 
second time by X-ray µCT. Data acquired at day 11th (sample-pre) and day 
14th (sample-post) were elaborated aiming to obtain the respective images, 
thus, an histogram of their gradient values distribution. 
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3.2 Finite Element Modeling of stress distribution 
A Finite Element Model (FEM) was implemented to investigate the stress 
distribution occurred, onto the scaffolds fibers, during the cell culture, 
when perfusion and/or compression stimuli are applied. The model was 
realized by using COMSOL Software; all the components were obtained 
using primitive geometry and boolean operation.  
3.2.1 Model culture unit 
Three-dimensional model of the culture unit was generated using cylindric 
geometries and boolean operations (Figure 3.5, [A]). The chamber unit 
dimension were 30 mm in length and 11 mm in height. The inlet/outlet 
diameter was 1.6 mm. The inner volume (Figure 3.5, [B]) was 
modeled as water. 
!  
Figure 3.5 - Three-dimensional modeling of the culture unit. A,  whole 
geometry; B, inner volume. 
A B
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3.2.2 Model scaffold 
A 3D model of the scaffold was generated using cylindric geometry, as 
shown in the following figure:   
!  
Figure 3.6 - Three-dimensional modeling of the scaffold. 
The scaffold dimensions were 5 mm in diameter and 6 mm in height. It 
was defined as a poroelastic material and initiated by specifying a random 
pore location. Materials properties were defined as follow: 
Table 3.1 - Scaffolds material parameters. 
All the requested parameters were chosen by Podichetty et al. 2013 [90]. 
Parameters Values Units
Density 35 [Kg/m3]
Young’s Modulus 9E+03 [Pa]
Permeability 7.27E-11 [m2]
Porosity 0.85 [ - ]
Poisson’s coefficient 0.8 [ - ]
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3.2.3 Model physics 
Laminar flow, based on the Darcy’s Law, and solids mechanics were set up 
as physics. To not affect the results, a sensitivity studies of the mesh was 
performed (Figure 3.7), in order to obtain the most computationally 
efficient mesh. 
!   
Figure 3.7 - Histogram of the elements quality. 
For the computational analysis different conditions were applied: only 
perfusion with a flow amount of 0.5, 1, 2, 5 mL/min, only compression 
with a deformation equal to 1, 2, 3, 5 % of the total scaffold volume, 
perfusion and compression with a values among those mentioned.  
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3.3 human Mesenchymal Stem Cells harvesting and culture 
The data presented in this manuscript were obtained using primary human 
bone marrow derived Mesenchymal Stem Cells (hMSCs) from a single 
donor (age 39) for a single experiment including a dynamic and a control 
static cell cultures. Cells were used at passage number two. Cells were 
acquired from Lonza inc (Allendale, NJ, USA) They were expanded in a 
monolayer in high glucose Dulbecco’s Modified Eagle Medium (DMEM) 
(Life Technologies, Carlsbad, CA, USA) containing 0.1% penicillin/
streptomycin (Life Technologies, Carlsbad, CA, USA), 0.1 mM non-
essential amino acids (Life Technologies, Carlsbad, CA, USA) and 10% 
fetal bovine serum (Life Technologies, Carlsbad, CA, USA). After two 
passages, hMSCs were trypsinized (Life Technologies, Carlsbad, CA, 
USA) and counted in an hemocytometer using Trypan Blue staining to 
evaluate the number of necrotic cells. 
3.4 Cell Media 
An osteogenic culture medium was formulated containing: high glucose 
DMEM, 40 mg/mL proline (Sigma-Aldrich, St. Louis, MO, USA), 0.1% 
penicillin/streptomycin (Life Technologies, Carlsbad, CA, USA), 0.1% 
sodium pyruvate (Life Technologies), 50 mg/mL ascorbate 2-phosphate 
(Sigma-Aldrich, St. Louis, MO), 0.1 mM dexamethasone, 1% ITS + 
premix (BD Biosciences, Bedford, MA), and 10 ng/mL TGF-b3 treatment 
(R&D systems, Minneapolis, MN). 
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3.5 Chitosan-graphene scaffolds 
Graphene oxide was supplied by National Institute for Research and 
Development in Microtechnologies (Romania), prepared according to 
Hummers procedure [91]. Acetic acid (99.7%) and chitosan from crab 
shells were purchased from Sigma-Aldrich (St. Louis, MO, USA). All 
materials were used without further purification and the water used in this 
work was double distilled water. 
2.5 g of Chitosan (CHT) were mixed with 250 ml acetic acid solution (10% 
by weight in water) at  50°C in order to form a homogeneous viscous 
solution. Further, different contents of graphene oxide (0; 0.5 and 3 % (wt/
vol) were added into CHT solution and mixed by ultrasonication for 1 h at 
room temperature. The homogeneous solutions were casted onto 
transparent glass Petri dish, then frozen overnight at -70°C and freeze-dried 
for 2 days at -50°C (0.040 mbar). After sublimation of ice crystals by 
freeze-drying, the polymer structure became porous. The 3D dried 
materials were thermally treated in vacuum, according to the following 
procedure: 50°C for 30 min, 70°C for 30 min and overnight at 90°C. The 
obtained samples were then subjected to advanced characterization of the 
bulk surface and to in vitro biocompatibility assessment [92]. 
3.6 3D cell culture 
Chitosan-graphene (CHT/G) scaffolds were seeded with hMSCs (1 x 106 
cells/mL) into a standard multi-well plate. After 1 hour some scaffolds were 
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placed into the bioreactor chambers. Starting from the 12 chitosan graphene 
scaffolds hosting hMSCs 2 groups were created: 6 scaffolds were placed in 
a petri dish for a static culture (control) while the others 6 scaffolds were 
placed in the six chambers of the bioreactor for a dynamic culture. The 
same osteogenic media was used and changed every 3 days in both 
cultures. 
The bioreactor was set up as follow: flow was driven by a peristaltic pump 
(WELCO WP10) at a flow rate of 1 mL/min for each chamber; the 
compression stimulus was applied at a frequency of 1 Hz and a 
displacement of 1 %. All the 6 dynamically cultured CHT/G scaffolds with 
hMSCs inside were exposed to perfusion flow for 14 days and to 
compression 2 times/day for 30 min each time, with a 1 % strain at 1 Hz. 
The whole system was maintained at 37°C and 5% CO2. 
3.7 Cell viability assay 
A working solution of approximately 2 µM calcein AM and 4 µM EthD-1 
was obtained adding 20 µL of 2 mM EthD-1 and 5 µL of the supplied 4 
mM calcein AM solution to 10 mL of sterile, tissue culture–grade PBS. 
A scaffolds slice was placed on the top of a 22 mm square coverslip and 
covered with 100 µL of the working solution, so that all cells were totally 
covered. Incubation was performed in a covered petri dish, to prevent 
contamination or drying of the samples, for 1h at room temperature and 
darkness. Following incubation, the sample was washed with PBS. 
!42
Using fine-tipped forceps, the wet coverslip was inverted and mounted over 
a microscope slide. To prevent evaporation, the coverslip was sealed to the 
glass slide with clear fingernail polish. Each sample obtained was analyzed 
under a fluorescence microscope. 
3.8 Von Kossa staining analysis 
In order to assess mineralization of extracellular matix (ECM), scaffolds 
maintained in both static and dynamic condition were stained and analyzed 
by optical microscope. 
To this aim, a standard Von Kossa staining protocol [93] was used to 
quantify the calcium/calcium salts deposition occurred during the ECM 
mineralization. 
CHT/G scaffolds were sectioned and, from each of those, two slices were 
collected and fixed, on top of a microscope slides, in cold methanol for 
15-20 min. After three rinses, the slides were incubated with 5% silver 
nitrate solution under a strong UV light. Thereby the calcium was 
visualized as metallic silver nodules as black spots. 
Von Kossa staining analysis was performed by acquiring 4 images from 
each slice treated and then comparing control group (static) vs dynamic 
group (bioreactor) data; to perform these measurements, qualitative and 
quantitative data were assessed. The images were acquired by using a 
Nikon TE 2000U optical microscope and processed, using the ImageJ 
software in order to: (i) detect the black spots obtained, for qualitative 
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analysis; (ii) calculate the amount of area covered from those spots, for 
quantitative analysis.  
Both the data were obtained using the max entropy segmentation, a method 
that allows to distinguish between the objectives (black spots) and 
background (scaffolds). 
Particularly, to quantify the amount of area covered (A) by the black spots 
the following formula was used: 
A = np⋅pd2 
where np is the number of pixels detected and pd is the pixel dimension.  
3.9 Statistical analysis 
A Shapiro-Wilk Normality test was performed to confirm that data display 
a normal distribution. Statistical evaluation was performed using a 
Student’s t-test to determine significant differences among groups. The 
significance level was set at P < 0.05.  
All results are presented as mean ± standard deviation. 
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4. Results 
The bioreactor system detailed in this manuscript is a novel stand-alone 
device that allows culturing 3D cell constructs within a controlled 
environment where tightly regulated compression and perfusion are 
administered, intended to address undifferentiated cells towards an 
osteogenic phenotype. Perfusion is aimed at improving diffusive 
exchanges, i.e. nutrient uptake and waste product removal. On the other 
hand, compression is applied to exert a mechanical strain over the cell 
onboard the scaffold, with the aim of addressing their phenotype 
commitment.  
Normally, when a new device has to be developed, three questions need to 
be answered: (idea) Which is the idea behind the device? (main function) 
Which functions the device has to satisfy? (novelty) There are already 
similar device on the market? Compared to devices present on the market, 
which might be the features that has to be included to define the device as 
“novel”?  
To answer to those questions, a series of steps is implemented building the 
device: create its design including all the required features; manufacture a 
prototype; test if it works as expected and, in case, debug it. 
Taking back these concepts to the bioreactor device development, the 
following list of answer were obtained: (idea) obtaining a device useful for 
bone tissue engineering; (main function) applying perfusion and 
compression aiming to reply the biomechanical stimuli physiologically 
related to the bone functioning; (novelty) compare to the bioreactor systems 
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present in the last 5 years literature, focusing on three main features: stand-
alone device, automatic media replacement option, real-time analysis of the 
tissue construct allowed. 
4.1 Design of the bioreactor system v 1.0 
!  
Figure 4.1 - Bioreactor system layout (v 1.0). Sketch front view of the 
bioreactor system set-up. 1, CO2 tank; 2, Automatic media replacement 
peristaltic pumps; 3, Fresh and waste media bottles; 4, Measurement 
chamber: temperature and pH sensors inside, heating pad (in yellow) 
below; 5, Gas exchange chamber; 6, Flow meter sensor; 7, Scaffolds units; 
8, Perfusion peristaltic pump; 9, device display unit. 
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Taking into account the requested innovative features the design of the 
bioreactor system, initially sketched as the version (v 1.0), is shown in the 
Figure 4.1. 
The layout illustrates a range (n=4) of rectangular culture units (Figure 4.1, 
[7]) each one hosting 3 scaffolds. All the culture units are under a 
continuous medium flow monitored by the flow meter sensor (Figure 3.1, 
[6]). Medium temperature and pH are constantly monitored and adjusted to 
37°C and 7.4, respectively, without the need of a dedicated cell culture 
incubator (i.e. the device can be located over a standard lab benchtop). 
Automatic culture medium replacement was operated by additional 
peristaltic pumps (Figure 4.1, [2]) from a fresh to a waste media bottles 
(Figure 4.1, [3]). A display unit (Figure 4.1, [9]) allows to set and monitor 
continuously all the culture parameter. 
An in silico evaluation was carried out to estimate the velocity profile 
occurring when perfusion is applied. Figure 4.2 shows a finite elements 
model (FEM) used for this assessment where geometries and material 
properties of the culture chamber were reproduced with the velocity profile 
occurring into the culture unit when a perfusion of 1 mL/min is applied. A 
laminar velocity profile with a mean velocity value of 0.04 m/s was 
calculated. No turbulences are apparent. 
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!  
Figure 4.2 - Computational fluid dynamics analysis. Velocity profile 
obtained within a scaffolds culture unit under continuous perfusion flow. 
4.2 Design of the bioreactor system v 2.0 
In order to address the bone tissue phenotype commitment the perfusion, 
aimed at improving diffusive exchanges, was coupled with compression 
intended to exert a mechanical strain over the cell onboard the scaffold. To 
administer the compressive stimulus, a changes to v 1.0 was performed. A 
new prototype versione was sketched as shown in the following figures. 
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Figure 4.3 - Bioreactor system layout (v2.0). Sketch front view of the 
bioreactor system set-up. 1, CO2 tank; 2, Automatic media replacement 
peristaltic pumps; 3, Perfusion peristaltic pump; 4, Measurement chamber: 
temperature and pH sensors inside, heating pad below; 5, Mechanical 
loading unit; 6, Fresh and waste media bottles. 
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Figure 4.4 - Bioreactor system layout (v2.0). Sketch side view of the 
bioreactor system set-up. 1, Scaffolds units; 2, Heating Pads. 
The device dimensions are 80L, 60W and 25H (cm). Suitable 
biocompatible materials (i.e. silicon Tygon® tubing and TuskT® culture 
units) were used for the cell interfacing environment, while polycarbonate, 
silicon, aluminum, or stainless steel were used for the other components of 
the device. 
To perform the perfusion a peristaltic pump (Figure 4.3, [3]) was included 
in a way to regulate the desired perfusion regimen through the bioreactor 
perfusion circuit. Although perfusion was described as a stimulus for 
phenotype commitment in several published bioreactor systems [80-82,94], 
we assumed that compressive load is the main physical cue in natural bone.  
2
1
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The perfusion flow was not intended to pass through the entire scaffold, but 
to flow over it, in a way to increase the diffusive exchange s from/to the 
culture medium (see in silico evaluation). 
!  
Figure 4.5 - Mechanical loading unit. Layout of the unit useful to apply 
mechanical compression onto seeded scaffolds hosted within the custom 
made chambers. 1, Aluminium case; 2, Stepper motor driving the 
compression plate screwed on it; 3, Custom made chamber; 4, Piston and it 
locker; 5, Load cell. 
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To this aim a custom made mechanical loading unit (Figure 4.3, [5]; Figure 
4.5) was used to compress the scaffolds, delivering a mechanical strain 
controlled in frequency and displacement. An aluminum case (Figure 4.5, 
[1]) was used as supporting structure for a stepper motor including a lead 
screw (Figure 4.5, [2]), useful to drive the vertical movement of an integral 
plate. The top of the plate hosts up to six culture units (Figure 4.5, [3]) in 
contact with adjustable pistons (Figure 4.5, [4]) able to compress the 
scaffolds within the chambers along with the plate strokes. The design 
includes the option of a load cell (Figure 4.5, [5]). 
As mentioned above a range of (n=6) culture units (Figure 4.6, [A]) were 
included in parallel alignment. The culture chamber (Figure 4.4, [1]; Figure 
4.5, [3]; Figure 4.6, [B]), which reproduces the volume of a single well of a 
standard 96-well plate, was modeled on the chosen design of our culture 
units. It is worth to note that the chamber design is a custom option, 
potentially adaptable to different scaffold dimensions, materials and shapes. 
Each culture unit allows to: host a single 3D scaffold and to maintain it 
under a continuous medium flow and a cyclic compression; easily connect/
disconnect a culture chamber from the perfusion line, thanks to the use of 
Spyros®/MicroClave® connectors avoiding risk of leakage from the fluid 
circuit. Each single unit is thus a mobile component (Figure 4.6, [A]). 
This approach allows to maintain, in the same in vitro culture condition, 
different small scaffolds (i.e.: ∼270 mm3), which are expected to be 
“sintered” at subsequent time of a potential in vivo implantation in a larger 
volume (i.e.: ∼1.5 cm3) promoting the vascularization process, thus, 
avoiding internal necrosis of the engineered tissue construct. 
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Furthermore, within the device medium temperature and pH are constantly 
monitored and adjusted to 37°C and 7.4, respectively, without the need of a 
dedicated cell culture incubator in a way to locate the device over a 
standard lab benchtop. 
An automatic culture medium replacement is operated by additional 
peristaltic pumps (Figure 4.3, [2]) from a fresh to a waste media bottles 
(Figure 4.3, [6]). In detail, at day 1st the bioreactor is filled with the cell 
media; then, every 3 days, the medium is replaced removing 80% of the 
exhausted medium (gathered into the waste media bottle) and adding the 
same quantity of fresh volume (collected from the fresh media bottle). In 
fact, preventing and minimize the infection risk is an important aspect to be 
maintained during a cell culture, so limiting the interaction with an external 
operator was considered an important feature for this device. In addition, an 
automatic media replacement protocol might allow to progressively (e.g. 
1mL/hr) replace the media, avoiding to administer to the cell culture the 
stress that is typically occurring with sheer media changes within 
traditional subculture procedures [95]. 
Finally, an in silico evaluation was carried out to estimate the stress 
affecting the scaffolds, therefore the cells onboard, when perfusion and/or 
compression are applied. 
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Figure 4.6 - Perfusion/compression culture chamber hosting a 3D scaffold. 
A, Removable culture unit; B, FEM modeled chamber (gray) and scaffold 
(blue); Stress impacting over the scaffold when perfusion (C),  compression 
(D) and perfusion/compression (E) are applied. 
Figure 4.6, [B] shows the finite elements model (FEM) used for this 
assessment where geometries and material properties of the culture 
chamber (gray) and of the scaffold (blue) were reproduced. The chitosan/
graphene (CHT/G) mechanical properties were used to model the scaffold. 
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Figure 4.6, [C, D, E] shows how perfusion, compression or perfusion/
compression together respectively affect the scaffold. The colorbar shows a 
relative range of stress values from lower (blue) to higher (red) figures. 
Figure 4.6, [C] shows the stress values occurring, onto scaffolds fibers, 
when only perfusion (flow amount 1 mL/min]) was applied; light blue 
color identifies low stress average values of about 10-5 Pa. On the other 
hand, Figure 4.6, [D] [E] show stress values, occurring onto scaffolds 
fibers, when only compression (1% of the total scaffold height) or either 
perfusion/compression (above-mentioned conditions) were applied; in both 
cases the same yellow/orange color distribution identifies higher stress 
values (average of about 10-1 Pa)  when compared to those elicited when 
only perfusion was applied. This result allows to consider the perfusion 
stimulus as negligible when compared to the compression stimulus, 
supporting the view that perfusion alone is a weak determinant to induce 
the cell towards the desired phenotype commitment. 
The in silico model allows to evaluate how perfusion and compression 
contribute during the cell proliferation/differentiation. In detail, as also 
reported in the reviewed literature: perfusion alone, with a flow rate of 1 
ml/min, is able to administer a stimulus useful to increase nutrient 
diffusion, thus the cell proliferation, but are negligible for inducing 
differentiation; compression alone, with a frequency of 1 Hz and 1 % of 
strain, procures stresses that are enough to address the cells towards the 
differentiation fate, but inhibits their proliferation. For this reason, for a 
proper tissue growth, both stimuli are required. 
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4.3 Operation of the bioreactor system 
Starting from the proposed design (v2.0), the prototype bioreactor system 
shown in the following figure was built. 
!  
Figure 4.7 - Bioreactor layout based on the proposed design (v2.0).  
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A detail of the compression/perfusion unit is shown in the following figure: 
!  
Figure 4.8 - Detail of the cell culture perfusion/compression unit. 
Aiming to manage easily the device, a Control Unit (CU) was built up and 
a Graphical Unit Interface (GUI) was implemented. Input to the actuators 
and data from sensors are constantly exchanged, in such a way to monitor 
these variables during the cell culture and to correct any of these if needed. 
4.3.1 CU design 
The CU of the bioreactor can be considered the functional core of the 
device. A prototype board was realized aiming to test each electrical/
electronic component. Its layout is shown in the following figure. 
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!  
Figure 4.9 - Control Unit prototype board.  
The board includes two drivers (Sparkfun EasyDriver® - Figure 3.10, [1]) 
useful respectively to control the peristaltic pumps involved in the 
automatic media replacement and the heating pads required to constantly 
maintain the cell culture at 37°C. Two others drivers (Sparkfun 
BigEasyDriver® - Figure 4.9, [2]) are used respectively to control the 
perfusion peristaltic pump and compression unit motor. A controller 
(Arduino Mega 2560® - Figure 4.9, [3]) is the processor unit employed to 
send, receive and elaborate data acquired during the bioreactor operation. A 
1
2
3
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series of capacitors and resistors were used into the configuration. A bench 
top power supply is used to power all the components. 
After testing, because of the presence of different wires and not stable 
elements, aiming to obtain a fixed and steady board, a customized 
electronic shield was realized, as shown in the following figure. 
!  
Figure 4.10 - Layout of the electronic shield. 
In the final version layout, all the components are welded to the shield. 
This is plugged on top of the Arduino. Compared with the prototype board, 
a series of plug and play connectors are used to connect and disconnect 
easily each actuator/sensor. All the drivers are plugged onto the shield 
through a series of female stacking headers, in a way to have the possibility 
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to replace them easily in case of break. A commercial power supply (12V, 
5A) is used to power each component. 
4.3.2 GUI 
With the aim to provide a system usable by anyone working in a tissue 
engineering laboratory, a user friendly graphical unit interface (GUI) was 
designed, as shown in the following figure: 
!  
Figure 4.11 - Graphical Unit Interface. Interface useful to tune all the 
actuators and to check all the operative parameters deriving from the 
sensors. 
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The interface allows to control easily the actuators through a series of 
virtual on/off switches and adjustable bars, simultaneously allowing the 
constant monitoring of each sensor.  
Compression stimulus can be performed setting the displacement [µm] and 
the frequency [Hz] of the compression plate integrated within the 
compression unit; two buttons (Up, Down) can be used to align the 
compression plate, rather, to allow the contact between the cylindrical 
scaffolds units and the pistons of the compression unit. Perfusion can be 
tuned changing the flow intensity [ml/min] related to the dedicated 
peristaltic pump. Automatic media replacement can be performed setting 
the “inflow” and “outflow" parameters [a.u.] related to the dedicated 
peristaltic pumps. In case of gas manual adjustment, within the 
measurement chamber, an air pump can be connected to the CU and the gas 
can be added/removed using respectively the “Gas in” “Gas out” switches. 
The desired culture temperature can be set through the “Set Temp” graphic 
element. Temperature [°C] , Pressure [kPa] and pH [-] can be monitored by 
dedicated scalebar. Two arrays (“Serial In”, “Serial Out”) are useful to 
check constantly if the right input/output are correctly sent/received to/from 
the CU. A “STOP” button is present to allow the interruption of all 
operations.  
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4.4 Effect of bioreactor system over cell viability and matrix 
mineralization  
The cells were cultured during 14 days either under a dynamic or a static 
(control) condition. In order to evaluate this novel bioreactor system in 
terms of ability to commit naive cells towards an osteogenic phenotype, 
perfusion and compression were transferred, onto 3D CHT/G scaffolds 
(Figure 4.12,  [A],[B]) hosting onboard human mesenchymal stem cells, 
(hMSCs) as biomechanical stimuli aiming to improve cell proliferation and 
differentiation respectively. Platelet lysate was used as soluble growth 
factor source, in a way to supply biochemical stimuli to both static and 
dynamic cultures. 
!   
Figure 4.12 - CHT/G scaffolds before bioreactor cell culture. A, empty 
scaffolds after their making and sterilization; B, scaffolds during hMSCs 
seeding; C, scaffolds maintained in a traditional static culture. 
A
B
C
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Both groups were initially maintained in a traditional static culture 
condition (Figure 4.12, [C]), to promote cell adhesion and proliferation 
over/within the scaffold. Subsequently, perfusion - aiming at improving 
nutrient exchange and waste removal - was applied to a group (n = 6) of 
cell-bearing scaffolds for 7 additional days together with compression 
aiming at the transfer to the cells of a mechanical stress intended as the 
stimulus for phenotypic cell commitment. To evaluate cell viability, 3 days 
after the beginning of dynamic culture (i.e. total culture day 10th), one 
scaffold from the bioreactor system and one maintained in static condition 
were evaluated by the live/dead® assay. 
!  
Figure 4.13 - Cell viability/proliferation (live/dead assay) within the 3D 
CHT/G scaffold under static (A / C = outer layer; B / D inner layer). 
A B
C D
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!  
Figure 4.14 - Cell viability/proliferation (live/dead assay) within the 3D 
CHT/G scaffold under dynamic (perfusion and compression) (A / C = outer 
layer; B / D inner layer). 
Figures 4.13 and 4.14 show cell distribution and viability inside (outer and 
inner layers) the CHT/G scaffolds comparing the static (Figure 4.13 [A],
[B]) vs. the dynamic (Figure 4.14 [A],[B]) culture. Comparing [B] panels 
from both Figures 4.13 and 4.14 show the increase of alive cells (green 
spots) in the core region of the dynamic vs. static condition. The expected 
perfusion contribution in improving nutrient exchange and waste removal 
determined a larger amount of viable cells under dynamic culture 
conditions, together with a consistently reduced number of necrotic cells 
A B
C D
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when compared to a traditional static culture protocol. A quantitative 
analysis was performed to confirm this initial evaluation. Image 
segmentation was used as tool to highlight the amount of scaffold area 
covered by either live or dead cells in static (Figure 4.13 [C],[D]) vs. 
dynamic (Figure 4.14 [C],[D]) condition, detailing the outcome measured 
within the outer and the inner layers of the scaffold, respectively.  
 
!  
Figure 4.15 - Dead area evaluated by a cell viability/proliferation (live/
dead) assay on CHT/G scaffolds. *Statistically significant difference 
(Student’s t-test; P<0.05). 
                                Static                         Dynamic                          Static                         Dynamic
                     Side                             Side                             Center                         Center
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!  
Figure 4.16 - Live area evaluated by a cell viability/proliferation (live/
dead) assay on CHT/G scaffolds. *Statistically significant difference 
(Student’s t-test; P<0.05). 
Figure 4.15 and 4.16 show the size of the scaffold area that can be 
attributed to viable/necrotic cells. A sizable effect of perfusion exchange 
enhancement under dynamic culture condition is particularly evident within 
the inner scaffold core, where more viable and less necrotic cells are 
present, when compared to traditional culture condition. On the other hand, 
apparently the absence of significant differences is observed when the outer 
scaffold layers are compared in static vs. dynamic conditions. This suggests 
that cell growth and proliferation are adequately sustained within the limit 
                                Static                         Dynamic                          Static                         Dynamic
                     Side                             Side                             Center                         Center
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of diffusion from surrounding medium in standard culture conditions. On 
the other hand, nutrient diffusion into the core of 3D tissue engineered 
tissue constructs was always considered to be hampered by the traditional 
static culture. The results obtained with our bioreactor system strengthen 
the strategy of supplying an appropriate perfusion flow to support nutrient 
influx and waste removal into/from the core of the scaffold. 
In addition to improving cell viability, our bioreactor system is expected to 
prime cell phenotype towards the osteogenic phenotype. Extracellular 
matrix (ECM) mineralization is among the hallmarks of the expected 
commitment, thus we evaluated our scaffolds upon Von Kossa staining of 
the CHT/G texture, after 7 days of dynamic vs. static culture. 
!  
Figure 4.17 - ECM mineralization (Von Kossa staining) within the core of 
the 3D CHT/G scaffold under static.
!  
Figure 4.18 - ECM mineralization (Von Kossa staining) within the core of 
the 3D CHT/G scaffold under dynamic (perfusion and compression). 
A B C
A B C
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Figures 4.17 and 4.18 show the Von Kossa stain within the core of a CHT/
G scaffold in static (Figure 4.17, [A],[B],[C]) vs. dynamic (Figure 4.18, 
[A],[B],[C]) culture. Panels 4.17, [A] and 4.18, [A] represent qualitative 
optical microscopy images where black spots from the Von Kossa stain 
appear supernumerary in the dynamic condition (Figure 4.18 [A]). 
 
!   
Figure 4.19 - ECM Mineralization evaluated by Von Kossa staining within 
the core of the 3D CHT/G scaffolds under static  (left) and dynamic 
(perfusion and compression) (right). *Statistically significant difference 
(Student’s t-test; P<0.05). 
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This was confirmed performing a quantitative analysis where image 
segmentation, obtained by using the max entropy method, highlights the 
amount of scaffold area covered by the Von Kossa elicited black spots in 
static (Figure 4.17 [B],[C]) vs. dynamic (Figure 4.18 [B],[C]) conditions. 
The ECM Mineralization obtained under static (Figure 4.19, [left]) and 
dynamic  (perfusion and compression) (Figure 4.19, [right]) conditions was 
evaluated. A statistical significance, related to the effect of the compression 
stimulus, is particularly evident within the core of the 3D CHT/G scaffolds 
maintained under dynamic culture condition, where a sizable ECM 
mineralization is present, when compared to traditional culture condition. 
4.5 Preliminary evaluation of the real-time/in-line monitor 
Each single mobile unit described above (Figure 4.6, [A]) might undergo 
real-time/in-line analysis (e.g. spectro(fluoro)scopy, X-ray µCT 3D 
imaging) to monitor the evolution of phenotype commitment before going 
back to the differentiation protocol within the device. This allows to keep 
track of a very same tissue construct during different days of dynamic cell 
culture.  
!69
!  
Figure 4.20 - Histograms of one scaffold processed by X-ray µCT. A, 
sample-pre; B, sample-post; C, pre (blu) and post (green) samples 
overlapped. 
A B
C
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Figure 4.20 shows very preliminary results about one scaffold hosted 
within a mobile unit and cultured for 10 days in static condition followed 
by 4 days into the bioreactor system. Histograms of images obtained by X-
ray µCT acquisition at day 11th (sample-pre, Figure 4.20, [A]) and day 
14th (sample-post, Figure 4.20, [A]) were extracted. Figure 4.20 shows the 
overlap between pre- (blue) and post- (green) samples histograms. An 
increase in the gradient distribution of the post-sample is present. The 
relationship with a biological effect will be evaluated in future experiments. 
On the other hand, is possible to confirm that real-time/in-line analysis can 
be performed without to interfere with the cell culture.  
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5. Discussion 
  
Although engineered bone tissue is been viewed as a potential alternative to 
the conventional use of natural bone grafts, due to its virtually limitless 
supply and the “clean” manufacturing procedure, however, bone tissue 
engineering practices have not proceeded to clinical practice yet. 
Likely responsible for this delayed progress are the poorly standardized 
applicative protocols, being the ex vivo fabrication of tissue engineered 
bone substitutes a complex process whose aspects need to be more 
carefully determined. In other words, there is still a need to recognize, 
assess, and arrange in order of importance the criteria to proceed towards 
tissue substitutes of high quality. 
Over the past decade, the field of tissue engineering (TE) has witnessed a 
significant progress, as a result of our improved understanding of biology, 
materials science, chemistry and engineering strategies, and the 
convergence of these disciplines [96]. As a consequence, present 
biofabrication technologies have enabled the manufacturing of complex 3D 
artificial tissues heralding better strategies for tissue/organ repair, with 
respect to the current traditional options. Thus, the TE approach has gained 
considerable attention as a promising strategy to heal bone defects, which 
are a significant health problem (resulting in billion annual healthcare 
costs) currently treated with grafts, decellularized bone, or synthetic bone 
grafts, with variably successful results. Looking towards future treatments 
for such defects, modern medicine was looking to bone grafts based on 
tissue-engineered substitutes grown in vitro and able to integrate with the 
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host [97]. To this aim, various biomaterials - both biomimetic synthetic 
polymers and biological molecules - manufactured via several fabrication 
techniques, were used as extracellular matrix substitutes with adequate 
biological and mechanical properties able to provide support for cell 
attachment, proliferation, and differentiation [98]. Autologous human 
Mesenchymal Stem Cells (MSCs), more specifically bone marrow-derived 
MSCs (hBM-MSCs) are suitable candidates to populate these scaffolds. In 
fact, given their proliferation potential, biomolecular production, cell-to-
cell signaling, and formation of appropriate extracellular matrix (ECM), 
they efficiently differentiate down the osteogenic path, and also secrete 
paracrine factors that may aid survival and vascularization of engineered 
bone [99]. Mechanostimulation also acts as a significant input to maintain/
induce bone phenotype [100], while increasing culture diffusive regimes 
[101]. In particular, compressive load was shown to significantly increase 
osteogenic markers in MSCs subjected to mechanical reconditioning [102]. 
Several bioreactors were used to impact mechanical stimuli to cells in 
culture. Some of them can also act as a stand-alone cell culture incubator 
able to transfer a controlled, recordable, and adjustable (cyclic) 
deformation to a 3D scaffold [70]. 
In summary, a combination of appropriate cells, biomaterials/scaffolds, and 
physical stimulation seems a successful approach to bone TE, but a 
standard protocol to optimally stimulate a 3D scaffold with MSC cells 
onboard, using a controlled mechanical deformation, to induce MSC fast 
osteogenic lineage commitment has to be released yet.  
Current scientific literature about using bioreactor system for bone tissue 
engineering is converging towards this objective.  
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Ding et al. 2016, shown as the combination of a mineral scaffold (i.e.: high 
Young’s modulus) with a low flow rate is enough to promote bone 
formation; on the other hand, Nguyen et al. 2016 and Sinlapabodin et al. 
2016 applied higher flow rates onto soft scaffolds (i.e.: low Young’s 
modulus) to obtain bone differentiation. From those, there is an evidence 
on how perfusion flow rate and scaffolds mechanical properties are 
straightly related. Different limits can be highlighted: (i) considering bone 
physiological stimuli, perfusion and  compression are present; particularly, 
compression plays a fundamental role during differentiation, thus, 
perfusion alone is not enough to reproduce correctly the bone physiological 
behavior. (ii) To apply compression stimulus, hard scaffold materials (i.e. 
PLA, PLGA, CaP, etc.) might be not appropriate, because an high load 
value might be applied to obtain a proper strain. (iii) soft scaffold materials 
(i.e.: alginate, chitosan, etc.) are useful to apply compression stimulus, but 
they might require high flow rates which might interfere with cells viability 
during dynamic culture.  
Brunelli et al. 2017, Maeda et al. 2017 and Revichandran et al. 2016 
described compression as a stimulus promoting mineralization but, at the 
same time, suppressing proliferation. As mentioned above, for a proper 
bone tissue differentiation, both perfusion and compression are necessary. 
Thus, compression alone is not enough to reproduce bone physiological 
behavior. Furthermore, compression effect on suppressing proliferation can 
be related with the perfusion absence, that is, a not appropriate nutrient 
diffusion and waste removal.  
To satisfy the presence of both perfusion and compression, suitable 
bioreactors were designed by Teng et al. 2016, Baumgartner et al. 2015, Li 
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et al. 2014, Petersen et al. 2012. Their results shown as: (i) perfusion is 
useful to enhance/increase cell proliferation; (ii) compression is a trigger 
for the osteogenic differentiation; particularly, comparing low and high 
frequencies cyclic compression, low frequencies are more effective; (iii) 
scaffold stiffness has only a temporary effect on cell behavior, while the 
impact of mechanical loading is preserved over time.  
Furthermore, Li et al. 2014 designed a stand-alone bioreactor, that is, a 
device that not require a dedicated cell culture incubator. 
The proposed current scientific literature shows how mechanical actuation 
devices play a fundamental role in obtaining an engineered bone tissue 
construct. Different kind of cells and 3D supports can be used without 
significative differences; on the other side it is clear how perfusion and 
compression fulfill each a specific role during tissue proliferation/
differentiation. Perfusion flow rate in a range of 1-3 mL/min leads to shear 
stresses promoting cell proliferation; on the other hand a flow rate higher 
than 3 mL/min causes shear stresses that lead to a decrease in the number 
of cells. Compression frequency in a range of 1-5 Hz is useful for a proper 
differentiation; compression at frequency lower than 1 Hz inhibits both cell 
proliferation and differentiation.  
Finally, only two of the proposed devices might be defined stand-alone. 
Having a standalone device can be considered an important feature: in fact, 
most of the bioreactor systems needs of a committed incubator to guarantee 
the maintenance of the standard cell culture parameters, requiring las space 
and resources that can be spared in the stand-alone configuration. 
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Starting to this paradigm, the aim of this study was to develop a novel 
perfusion/compression bioreactor system as efficient tool for tissue 
engineering approach. Based on this idea, the bioreactor was designed as a 
compact unit including a mix among: proved features as perfusion/
compression and stand-alone apparatuses; innovative features as automatic 
media replacement system and real-time/in-line monitor.  
Perfusion and compression apparatus was included to apply proper 
physical stimuli during bone tissue commitment. As mentioned above, 
perfusion is aimed at improving diffusive exchanges, i.e. nutrient uptake 
and waste product removal; on the other hand, compression is applied to 
exert a mechanical strain over the cell onboard the scaffold, with the aim of 
addressing their phenotype commitment.  
A stand-alone apparatus was introduced in a way to avoid the use of a 
dedicated cell culture incubator, that is, to locate the device over a standard 
lab benchtop. 
A system of automatic replacement of the media was incorporated in order 
to: facilitate the replacements of the media avoiding to administer to the 
cell culture the stress that is typically occurring with sheer media changes 
within traditional subculture procedures; prevent contamination due to 
manual operation. 
A real-time/in-line monitor was designed to easily perform at different time 
point on the same tissue construct specific analysis (e.g.: 
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spectrofluorometric analysis, fluorescence analysis; X-ray µCT for 3D 
imaging analysis). 
Before to use the bioreactor device a series of test were performed: (i) 
culture parameters (i.e.: temperature of 37°C and ph of 7.4) were monitored 
for a week aiming to verify the stability of the system: no fluctuation were 
detected; (ii) each bioreactor component was sterilized, placed in the 
bioreactor and the absence of possible contamination was monitored for a 
week: no contamination was detected; an in silico evaluation was carried 
out to estimate the stress affecting the scaffolds, therefore the cells onboard, 
when perfusion and/or compression are applied: no apparent turbulences 
were detected and stress values in a range of 10-5÷10-1 [Pa] were measured 
During the dynamic culture, a perfusion flow rate of 1 [ml/min] was used 
to guarantee appropriate diffusive exchange without, at the same, interfere 
with the cell viability. A dynamic compression 2 times/day for 30 min each 
time, with a 1 % strain at 1 Hz was applied to address specific 
differentiation stimuli. The effect of perfusion and compression stimuli on 
cell behavior (proliferation/differentiation respectively) was evaluated at 
different time point. 
Proliferation was investigated, at day 3 of the dynamic culture, through a 
cell viability assay: qualitative/quantitative data shown as the expected 
perfusion contribution in improving nutrient exchange and waste removal 
determined a larger amount of viable cells under dynamic culture 
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conditions, together with a consistently reduced number of necrotic cells 
when compared to a traditional static culture protocol. This suggests that 
cell growth and proliferation are adequately sustained within the limit of 
diffusion from surrounding medium in standard culture conditions. On the 
other hand, nutrient diffusion into the core of 3D tissue engineered tissue 
constructs was always considered to be hampered by the traditional static 
culture. 
Osteogenic differentiation, this is, ECM matrix mineralization was 
evaluated through Von Kossa staining: qualitative/quantitative data 
confirmed that our bioreactor system is apt to transfer to the scaffold a 
relevant mechanical cue which is translated into a sizable biological effect.  
A specific test for the assessment of the real-time/in-line monitor was 
performed. Very preliminary results shown that the same sample, thus, the 
same construct can be processed by X-ray µCT, at different time point, 
without to interfere with the cell culture. The relationship among the 
obtained data and the biological effect will be evaluated in future 
experiments. 
Comparing this with the previously manufactured bioreactors, it is possible 
to conclude how the developed device: (i) is able to reproduce the 
perfusion/compression regimens useful for a proper proliferative/
differentiative response; (ii) is a stand-alone device, which means that 
different experiments can be performed onto a standard lab bench top, 
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without the need of a committed incubator; (iii) allows an automatic cell 
media replacement preventing the risk of contamination; (iv) includes an 
innovative feature which allows to perform a real time/inline analysis, at 
different time points on the same scaffold, avoiding the necessity to apply 
destructive technique to asses the tissue construct during the whole culture. 
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6. Conclusion 
The main focus of this work is the development of an innovative bioreactor 
system for human bon tissue engineering. This device is useful to 
reproduce physiologic mechanical solicitations, recognized as fundamental 
cues actives over natural tissues. Especially, human bone tissue is normally 
subjected to two forms of biomechanical stimuli: compression/tension 
loading generating fluid movement through lacunae and physical 
deformation generating structural change. In order to address the bone 
tissue phenotype commitment the perfusion aimed at improving diffusive 
exchanges was coupled with compression intended to exert a mechanical 
strain over the cell onboard the scaffold. 
The developed bioreactor was designed integrating both proved and 
innovative features aiming to work easily and safety improving the 
processes involved during osteogenic lineage commitment. 
This is realized through the use of a series of sensors, actuators and suitable 
biocompatible materials used for the cell interfacing environment, while 
polycarbonate, silicon, aluminum, or stainless steel were used for the other 
components of the device. 
The complete description of the device and of its realization is reported in 
detail together with a validation obtained comparing the results of the tissue 
construct cultured in dynamic condition vs. static condition (control). 
Furthermore, a really preliminary result about real-time/in-line monitor is 
shown, to evaluate the possibility of performing the same analysis on the 
same tissue construct at different time point.  
!80
The obtained results confirming that this bioreactor system is apt to transfer 
to the scaffold a relevant mechanical cue which is translated into a sizable 
biological effect. 
A series of future developments are required: (i) a set of generic 
experiments to produce robust biological data; (ii) a set of specific 
experiments to evaluate how the compression stimulus may promote the 
phenotype commitment without the need of soluble growth factors added to 
the culture; (iii) a revision of the device structure aiming to shift from a 
prototype version to a final version of the device; (iv) a standard protocol to 
optimally stimulate a 3D scaffold with MSC cells onboard, using a 
controlled mechanical deformation, to induce MSC fast osteogenic lineage 
commitment. 
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Appendices 
Appendix A 
Equipment 
Table 1. Reagents used for harvesting stems cells 
Table 2. Components used for harvesting stems cells 
Reagent Manifacturer
DMEM F12 + Glutamax medium Life Technologies, Carlsbad, CA, USA
Penicillin-Streptomycin Life Technologies, Carlsbad, CA, USA
Fetal Bovine Serum
(heat inactivated or MSC 
screened)
Life Technologies, Carlsbad, CA, USA
PBS Life Technologies, Carlsbad, CA, USA
Confluent hBM-MSCs cells in 
monolayer Lonza inc, Allendale, NJ, USA
0.1% Gelatin Sigma Aldrich, St. Louis, MO, USA
0.25% Trypsin Life Technologies, Carlsbad, CA, USA
Component Manifacturer
75cm cell culture flasks Nunc, Penfield, NY, USA
Tubes (15 and 50 ml) Falcon, Franklin Lakes, NJ, USA
Pipettes and tips Gilson, Middleton, WI, USA
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Table 3. Devices used for harvesting stems cells 
Protective equipment should be worn while handling the components of 
this assay. Wear lab coat, protective gloves and safety googles at all times. 
hES-MP002.5 are cells of human origin. Same procedures that apply to 
other tissue of human origin such as blood should be followed. 
Table 4. Precautions for the components used during harvesting stems cells 
Device Manifacturer
Centrifuge Thermo Scientific, Vantaa, Finland
Incubator (5% CO2, 95% H2O) N/A
Component Storage Hazards and Precautions
DMEM F12 +glutamax 4-8°C Not dangerous
Penicillin Streptomycin -20°C
Danger
Skin corrosion, serious 
eyes damage, 
respiratory and skin 
sensitization, 
reproductive toxicity
Fetal bovine serum -20°C Not dangerous
Platelet lysate -20°C Not dangerous
Sterile Gelatin 4-8°C Not dangerous
Sterile PBS RT Not dangerous
Trypsin -20°C Not dangerous
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Procedure 
Preparation of solutions 
For the preparation of cell culture media, the following protocols was 
applied: 
• Preparation of Culture media with 10% FBS in DMEM F12 +glutamax. 
Preparation of 0.1% gelatin solution 
• Bringing 2% gelatin stock solution to room temperature.  
• Working under sterile conditions in a clean hood with the fan on.  
• In a 50 ml tube mixing 47,5 ml sterile H2O with 2,5 ml 2% gelatin.  
• Storing at 4-8°C.  
Coating cell culture flasks and preparation  
• Blending media or obtaining already prepared media  
o Making sure that media has 0.1% Penicillin streptomycin and 10% 
supplement (either  bbPL or FBS)  
o If using platelet lysates (PL) making sure that media has 4IU/ml of 
heparin 
• Bringing the media and the trypsin to 37°C in the shaking plate incubator  
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• If preparing cells to be reseeded, working sterile and add 5 ml of 0.1% 
gelatin solution to a sterile 75cm2 cell culture flask (67µl/cm2) or other 
culture vessel of your choice.  
• Close the flask, allowing the gelatin to completely float over the culture 
surface and keeping at 4-8°C for at least 30 min.  
• Making sure that your flask is carefully labeled with your name, date, cell 
type, media type and passage number.  
Harvesting cells 
  
• Preparing the laminar flow hood with clean o Pipettes and tips 
   o Waste container with chlorinated water o Empty lab tubes  
   o Reagents to be used 
• Obtaining the cell culture from the incubator and placing inside the hood.  
• Loosening the cap and pouring the media into the waste container.  
• Transfering 5 ml sterile PBS (67µl/cm2) into the cell culture flask. Close 
the flask and allowing the PBS to float over the culture surface by 
rocking the flask gently.  
   o This will wash excess media from the culture flask and ensure better    
        effectiveness of the trypsin in next steps. 
• Pouring the PBS off and then putting 5 ml of warmed Trypsin into the 
flask.  
• Close the flask and putting it into the incubator for 5 min  
   o The trypsin, as a digestive enzyme, will release the cells from the  
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       plastic surface. 
  o When the cells are released they will appear small, round and bright in  
      the microscope and float around creating a “snow storm” impression. 
   o In this step the cells should be monitored carefully since  prolonged  
     trypsin digestion can harm the cells. When the cells are released proceed  
     immediately to next step. 
• Returning the cell culture flask into the hood and adding 5 ml of pre-
warmed media into the flask. 
   o The supplemented media will help neutralize the trypsin and stop the  
      digestion. 
• With the aid of a pipettboy, using the cell solution inside the flask to 
wash the culture surface and then transferring the solution to a 15 ml 
tube.  
• Centrifugating for 5 min at 1750 rpm.  
• Pouring of the supernatant into the waste container and resuspending the 
cells in 1 ml culture media.  
   o If the cell solution is dense, like when combining cells from many  
     culture flasks into a single tube, resuspend the cells in as many ml as the  
     number of culture flasks. 1 culture flask = 1 ml. 
• Proceed to cell counting. Seeing the following protocol: 
   o Counting cells with hemocytometer 
• When the number of cells was obtained they can be reseeded, frozen or 
used for experimentation.  
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• If reseeding, using gelatin coated culture flask and using 5500 cells/cm2 
seeding density.  
Precautions 
Use sterile working techniques without exceptions when handling cells for 
culture. 
This includes cleaning everything with ethanol prior to entering the hood, 
including gloved hands. 
Always use a clean water-bath. Mark the medium bottle as supplemented 
and write your name and date (as for all solutions you work with). Always 
take the volume you expect to need from the a stock bottle for media or 
PBS and place in a different sterile container (like 50 ml plastic tubes) 
before continuing work. This is to prevent contaminating your medium 
bottle. Do not spray ethanol on culture flasks because the cells are sensitive 
to ethanol. 
!88
Appendix B 
Equipment 
Table 1. Reagents used for counting cells 
Table 2. Components used for counting cells 
Table 3. Devices used for counting cells 
Reagent Manifacturer
Trypan Blue Gibco, Grand Island, NY, USA
PBS Gibco
Cell solution of unknown 
concentration -
Component Manifacturer
Microtubes Sarstedt, Nümbrech, Germany
Pipettes and tips Gilson, Middleton, WI, USA
Device Type Producer
Hemacytometer Neubauer Assistant, Munich, Germany
Cell counter - N/A
Microscope Leica DM IRB
Lumenera, Capella 
court, Ottawa, ON, 
Canada
Calculator - N/A
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Protective equipment should be worn while handling the components of 
this assay. Wear lab coat, protective gloves and safety googles at all times. 
Table 4. Precautions for the components used during counting cells 
Procedure 
Preparation of stained cell solution 
• To a microtube adding  
o 50µl Trypan Blue 
   o 30 µl PBS 
   o 20µl Cell solution.  
• Mixing well 
• Note! Never bring your cell solution outside of the cell hood.  
o You want your cell solution to remain sterile. Simply transfer a sample 
Component Storage Hazards and Precautions
Trypan Blue RT
Danger
May cause cancer 
Suspected of causing 
genetic defects 
Suspected of damaging 
fertility or the unborn 
child
PBS RT Not dangerous
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of the cell solution into the staining solution inside the hood under sterile 
operating procedures.   
• Afterwards, the staining solution containing the cell sample can be 
brought outside the hood. 
Cell Counting 
• Preparing the counting chamber  
o Making sure the counting surface of the Neubauer hemacytometer is 
clean  
o Placing the cover slide on top of the counting surface  
   o The cover slide will stay in place on the counting chamber via  
  capillary force. Trying to breathe gently on the glass and then     
        placing it  immediately on the counting chamber.  
• With a pipette transferring a small amount of the cell solution into the 
hemocytometer by placing the tip at the end of the cover slide and gently 
allowing the solution to be drawn under cover slide until the area is 
covered. Do not overfill.  
• Counting all the cells in the four big corner squares. Excluding cells that 
stain blue.  
• If more than 200 cells are counted per big square, diluting the solution 
and repeating.  
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Calculation 
• The volume of each square is 1 mm3 or 10-3 cm3. 1 cm3 equals 1 ml so 
the count can be found with the following formula:  
Cells/ml = Average count per square * dilution factor * 104  
• If the protocol above is followed the total cell count is divided by 4 and 
the dilution factor is 5  
!  
  
• To obtain the total cell count of the original solution, the outcome is 
simply multiplied by the original volume of the solution  
• It’s recommended to count each stained solution few times (2-4 times) 
and mix thoroughly between counts to obtain more accurate results.  
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Figure 1. Microscope and cell counter. 
Precautions 
Use sterile working techniques without exceptions when handling 
materials intended for cell culture.  
This includes cleaning everything with ethanol prior to entering the hood, 
including gloved hands.  
Tryphan blue is a histological dye to stain tissues. Wearing protective 
gloves and safety googles is recommended since both fingers and eyes are 
covered with tissue that you don’t want to stain! 
Wear lab coat, the stain will not wash out of clothes. 
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Appendix C 
Equipment 
Table 1. Reagents used for cell culture  
Table 2. Components used for cell culture 
Table 3. Devices used for cell culture 
Protective equipment should be worn while handling the components of 
this assay. Wear lab coat, protective gloves and safety googles at all times. 
Reagent Manifacturer
Cell culture media (e.g. a-MEM, 
DMEM) Life Technologies, Carlsbad, CA, USA
Cell culture supplement (e.g. FBS, 
hPL) -
Cell solution (e.g. MC3TE, MSC or 
hES-MP) -
Component Manifacturer
24 well plate – non-tissue treated BD Falcon, Franklin Lakes, NJ, USA
Sterile chitosan/graphene scaffolds Bloodbank, Reykjavik, Iceland
Pipettes and tips Gilson, Middleton, WI, USA
Device Producer
Centrifuge Thermo Scientific, Vantaa, Finland
Incubator (5% CO2, 95% H2O) N/A
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Procedures 
• Obtaining the plate with 6 scaffolds in cell culture medium from the 
overnight incubation. 
• Removing the scaffolds from the medium and placing in a new 24-well 
plate. 
• Allowing the scaffolds to dry for 1 hour at 37°C in the bench top 
incubator 
• Adjusting your cell solution to 4000 cells/µl (100.000 cells/ 25µl) 
• Obtaining the correct amount of cells needed in a test tube. 
    o You need 100.000 cells per scaffold 
• Centrifuging for 5 min at 1750 rpm (545 x g) 
• Discarding the supernatant 
• Resuspending the cells in 25µl of cell culture media for each scaffold. 
• Seeding 25 µl (100.000 cells) drop by drop on each scaffold and 
incubating in the CO2 incubator for 15 min. 
    o Mixing the cell solution well prior to seeding each scaffold. 
• After 15 min, removing the scaffold-plate from the incubator and 
aspirating and reseeding any medium that has leaked from the scaffolds. 
• Returning the plate to the incubator for another 15 min. 
• Repeating for a total of 4 times. 
• At the end of the 4th seeding 
   o Getting 3 of 6 scaffolds and add it into the 3 wells of 24-well plate;     
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       after  adding 1 ml media for each well. 
   o Getting the remaining 3 scaffolds and adding it into the bioreactor;  
       after adding the necessary media. 
• Returning to the incubator for culture. 
Precautions 
Use sterile working techniques without exceptions when handling cells 
for culture.  
This includes cleaning everything with ethanol prior to entering the hood, 
including gloved hands.  
Mixing the cell solution prior to seeding is important. No blending will 
result in inaccurate seeding density and negatively affect the experiment.  
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